4//SEC Filing
Anacor Pharmaceuticals, Inc. 4
Accession 0001209191-16-092996
CIK 0001411158operating
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 9:00 PM ET
Size
14.9 KB
Accession
0001209191-16-092996
Insider Transaction Report
Form 4
IPPOLITO VINCENT P
EVP & Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2016-01-19$19.96/sh+20,000$399,200→ 90,985 total - Exercise/Conversion
Stock Option (right to buy)
2016-01-19−20,000→ 61,000 totalExercise: $19.96Exp: 2024-03-06→ Common Stock (20,000 underlying) - Sale
Common Stock
2016-01-19$96.00/sh−5,300$508,797→ 71,185 total - Sale
Common Stock
2016-01-19$93.92/sh−1,200$112,704→ 89,785 total - Sale
Common Stock
2016-01-19$95.29/sh−13,300$1,267,313→ 76,485 total - Sale
Common Stock
2016-01-19$96.95/sh−200$19,390→ 70,985 total
Footnotes (6)
- [F1]This sale was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.68 to $94.575, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4) and (5) to this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.72 to $95.63, inclusive.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.78 to $96.74, inclusive.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.84 to $97.06, inclusive.
- [F6]The award is subject to a four-year vesting period, with 25% of the shares subject to the award vesting in an initial annual installment following the Vesting Commencement Date and 1/48th of the shares subject to the award vesting each month thereafter. The Vesting Commencement Date was February 28, 2014.
Documents
Issuer
Anacor Pharmaceuticals, Inc.
CIK 0001411158
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001411158
Filing Metadata
- Form type
- 4
- Filed
- Jan 20, 7:00 PM ET
- Accepted
- Jan 21, 9:00 PM ET
- Size
- 14.9 KB